Loading

Partnering for Progress: Exploring Biotech Innovations and Opportunities in Saudi Arabia

June 17, 2025
Super Session
253ABC
This session will open with an overview of Vision 2030 and explanation of the Kingdom’s commitment to the role of biotech in advancing healthcare. A panel discussion will then explore the key drivers of biotechnology advancement in Saudi Arabia and the opportunities for international partners. Leaders in healthcare, regulation, and investment will discuss how a synergistic approach to clinical trials, regulatory frameworks, and strategic partnerships can propel the Kingdom to the forefront of biotechnology innovation. Sponsored by: Saudi Biotechnology
Moderator
Ranch Kimball
Senior Advisor
Boston Consulting Group (BCG)
Speakers
H.E. Dr. Majid Al Fayyadh
Chief Executive Officer
King Faisal Specialist Hospital and Research Centre
Prof. Fars Kaed Alanazi
Chief Executive Officer
Saudi National Institute of Health (SNIH)
Prof. Dr. Hisham Saad AlJadhey, PharmD, PhD
Chief Executive Officer
Saudi Food and Drug Authority
H.E. Dr. Bandar AlKnawy, MD, FRCPC, FRCP (edin)
Chief Executive Officer of the Ministry of National Guard Health Affairs (MNGHA) and President
King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Saudi Arabia
H.E. Abdulaziz Hamad Alramaih
Vice Minister of Health for Planning and Development
Saudi Arabia
Raid bin Abdullah Ismail, MBA
Senior Director, Co-Head of Direct Investments, & Head of Operation Value Creation MENA Investments Division
Public Investment Fund (PIF)

Sponsored by:

saudi biotech

 

Back to Session List

white squarewhite

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS